AN UNDETECTABLE PB MRD STATUS SHOULD BE THE THERAPEUTIC GOAL WITH VENETOCLAX THERAPY IN RELAPSED/ REFRACTORY CLL S.M. Handunnetti,T.E. Lew, V.S. Lin,M.A. Anderson, D. Carney,M. Wolf, N. Came, S. Juneja,D. Westerman,C.S. Tam,A.W. Roberts,J.F. SeymourHematological Oncology（2019）引用 0|浏览32暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
